Oncology Research Information Exchange Network in Improving Genetic Screening Rate in Patients With Cancer

Withdrawn before enrolling

Conditions studied: Malignant Neoplasm

In brief

This research trial studies how well Oncology Research Information Exchange Network (ORIEN) works in improving genetic screening rate in patients with cancer. Implementation of Progeny Genetic Pedigree and Family History Questionnaire software across all ORIEN member institutions may add value and utility for recognizing and caring for patients with an inherited susceptibility to cancer.

Key facts

Study ID

NCT03348137

Run by

University of Southern California

People needed

0

Starts

2019-07-01

Expected to finish

2038-07-01

Last updated by the study team

2019-10-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Limited to those patients who are consented to the Total Cancer Care Protocol (TCCP) protocol
• Able to understand and sign the TCCP informed consent, California subject?s bill of rights, Health Insurance Portability and Accountability Act (HIPAA), and research authorization form directly or through an authorized representative; the informed consent, subject?s bill of rights, HIPAA, and research authorization will be available in both English and Spanish languages

You may not qualify if…

• Individuals who are not registered as patients for outpatient or inpatient care to the TCCP protocol
• Individuals who are unable to understand or sign the TCCP informed consent, subject?s bill of rights, HIPAA, and research authorization in either English or Spanish

Where it is running

• USC / Norris Comprehensive Cancer Center — Los Angeles, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.